Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ghanem

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Acta Pharmaceutica Hungarica|November 1, 1996
Bioequivalence study of two capsule formulations of omeprazoleG K Pillai, M S Salem, N M Najib, et al.
Pesticide Biochemistry and Physiology|January 4, 2017
Acetylcholinesterases from entomopathogenic nematode Heterorhabditid bacteriophora: Susceptibility to insecticides and immunological characteristicsMagda A Mohamed, El-Sayed M E Mahdy, Abd-El-Hady M Ghazy, et al.
International Journal of Biological Macromolecules|November 22, 2019
Purification and characterization of acetylcholinesterase in Rhynchophorus ferrugineus (Olivier) (Coleoptera: Curculionidae)Magda A Mohamed, Shebl Shaalan, Abd-Elhady M Ghazy, et al.
Expert Review of Anti-Infective Therapy|May 19, 2020
Value of IFNL3 genetic polymorphism in the prediction of HCV treatment response to direct-acting antiviral drugs versus interferon therapySamar E Ghanem, Maha Elsabaawy, Nashwa Shebl, et al.
Frontiers in Oncology|December 6, 2021
Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational ValueAhmad Najem, Jasper Wouters, Mohammad Krayem, et al.
Cancers|December 23, 2023
Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. <i>Cancers</i> 2019, <i>11</i>, 1093Mohammad Krayem, Malak Sabbah, Ahmad Najem, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|November 8, 2015
The activity of detoxifying enzymes in the infective juveniles of Heterorhabditis bacteriophora strains: Purification and characterization of two acetylcholinesterasesMagda A Mohamed, El-Sayed M E Mahdy, Abd-El-Hady M Ghazy, et al.
Gene Therapy|May 24, 2000
Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vectorF Dupont, B Avalosse, A Karim, et al.
Cancers|August 4, 2019
The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in MelanomaMohammad Krayem, Malak Sabbah, Ahmad Najem, et al.
European Journal of Medicinal Chemistry|July 1, 2018
Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cellsAmel Djehal, Mohammad Krayem, Ahmad Najem, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Acta Pharmaceutica Hungarica|November 1, 1996
Bioequivalence study of two capsule formulations of omeprazoleG K Pillai, M S Salem, N M Najib, et al.
Pesticide Biochemistry and Physiology|January 4, 2017
Acetylcholinesterases from entomopathogenic nematode Heterorhabditid bacteriophora: Susceptibility to insecticides and immunological characteristicsMagda A Mohamed, El-Sayed M E Mahdy, Abd-El-Hady M Ghazy, et al.
International Journal of Biological Macromolecules|November 22, 2019
Purification and characterization of acetylcholinesterase in Rhynchophorus ferrugineus (Olivier) (Coleoptera: Curculionidae)Magda A Mohamed, Shebl Shaalan, Abd-Elhady M Ghazy, et al.
Expert Review of Anti-Infective Therapy|May 19, 2020
Value of IFNL3 genetic polymorphism in the prediction of HCV treatment response to direct-acting antiviral drugs versus interferon therapySamar E Ghanem, Maha Elsabaawy, Nashwa Shebl, et al.
Frontiers in Oncology|December 6, 2021
Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational ValueAhmad Najem, Jasper Wouters, Mohammad Krayem, et al.
Cancers|December 23, 2023
Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. <i>Cancers</i> 2019, <i>11</i>, 1093Mohammad Krayem, Malak Sabbah, Ahmad Najem, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|November 8, 2015
The activity of detoxifying enzymes in the infective juveniles of Heterorhabditis bacteriophora strains: Purification and characterization of two acetylcholinesterasesMagda A Mohamed, El-Sayed M E Mahdy, Abd-El-Hady M Ghazy, et al.
Gene Therapy|May 24, 2000
Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vectorF Dupont, B Avalosse, A Karim, et al.
Cancers|August 4, 2019
The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in MelanomaMohammad Krayem, Malak Sabbah, Ahmad Najem, et al.
European Journal of Medicinal Chemistry|July 1, 2018
Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cellsAmel Djehal, Mohammad Krayem, Ahmad Najem, et al.
Pageof 9